
    
      This is a 6-month, single-site, double-blind, controlled study in 20 female subjects with
      mild to moderate facial acne. Subjects will be randomized 1:1 to apply either topical Next
      Science™ acne cream 2x or Next Science™ acne cream 1x daily. Subjects will be evaluated for
      clinical acne and quality of life outcomes at baseline, 6, 12, 18 and 24 weeks.
    
  